Citadel Advisors »

Intellia Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $46M 1.5M 30.49
2023-09-30 $69M 2.2M 31.62
2023-06-30 $73M 1.8M 40.78
2023-03-31 $47M 1.3M 37.27
2022-12-31 $47M 1.3M 34.89
2022-06-30 $31M 601k 51.76
2022-03-31 $46M 636k 72.67
2021-12-31 $44M 372k 118.24
2021-09-30 $49M 363k 134.15
2021-06-30 $116M 716k 161.91
2021-03-31 $70M 873k 80.26
2020-12-31 $70M 1.3M 54.40
2020-09-30 $18M 914k 19.88
2020-06-30 $18M 835k 21.02
2020-03-31 $12M 966k 12.23
2019-12-31 $11M 754k 14.67
2019-09-30 $2.6M 198k 13.40
2019-06-30 $3.3M 202k 16.36
2019-03-31 $2.5M 148k 17.08
2018-12-31 $1.3M 92k 13.65
2018-09-30 $2.8M 99k 28.61
2018-06-30 $1.8M 66k 27.37
2018-03-31 $3.0M 144k 21.10
2017-12-31 $1.5M 80k 19.23
2017-09-30 $1.2M 49k 24.84